On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Neurodegenerative disease (1)
- Neurodegenerative disease (2)
- Neurodegenerative disease (3)
- What causes neurodegenerative diseases?
- Misfolded aggregates deposited in the brain
- Role of protein aggregates in disease
- Research strategy
- Prion diseases
- Two conformations of the prion protein
- Brain alterations in prion diseases
- Experimental scrapie model in mice
- Sequence of events in scrapie pathogenesis
- ERp57 upregulation
- ERp57 and PrPSc correlation in the brain
- Upregulation of other ER chaperones
- ER-stress and UPR in human CJD
- The UPR pathway
- XBP-1 conditional KO did not affect prion disease
- PrP interaction with ER chaperones in brain
- PrPSc induces neuronal death in vitro
- PrPSc induces ER-stress in vitro
- Prion infection sensitizes cells to ER-stress
- Calcium release comes from the ER
- Hypothesis: Prion formation leads to ER stress
- Calcineurin properties
- Signaling pathways
- Calcineurin is implicated in PrPSc toxicity
- A novel treatment for prion diseases
- Treatment improves symptoms (behavior)
- Treatment increases animal survival
- FK506 effect on calcineurin and its targets
- Treatment decreases neuronal death
- Treatment decreases neurodegeneration
- Conclusions
- Acknowledgment
- Former lab members
Topics Covered
- Neurodegenerative disease
- Misfolded aggregates deposited in the brain
- Research strategy
- Prion diseases
- Two conformations of the prion protein
- Experimental scrapie model in mice
- Upregulation of ER chaperones
- ER-stress and UPR in human CJD
- PrP interaction with ER chaperones in brain
- PrPSc induction of ER-stress and neuronal death
- Calcineurin properties
- A novel treatment for prion diseases
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Soto, C. (2012, February 2). Endoplasmic reticulum stress in neurodegenerative diseases [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/KWGE4872.Export Citation (RIS)
Publication History
- Published on February 2, 2012
Financial Disclosures
- Prof. Claudio Soto has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.